Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses

European Heart Journal

Volumn 25, Issue 22, 2004, Pages 2034-2039

  Barbato, Emanuele ^a   Bartunek, Jozef ^a   Aarnoudse, Wilbert ^b   Vanderheyden, Marc ^a   Staelens, Frank ^a   Wijns, William ^a   Heyndrickx, Guy R ^a   Pijls, Nico H J ^b   De Bruyne, Bernard ^a  

^a CARDIOVASCULAR CENTER AALST   (Belgium)

^b CATHARINA HOSPITAL   (Netherlands)

Author keywords

Adenosine; Alpha blockers; Coronary Hyperaemia; Fractional Flow Reserve; Phentolamine; Urapidil

Indexed keywords

ADENOSINE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR; PHENTOLAMINE; SODIUM CHLORIDE; URAPIDIL;

ADULT; ARTERY DIAMETER; ARTERY RESISTANCE; ARTICLE; BLOOD PRESSURE; CALCULATION; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY PRESSURE; DECISION MAKING; FEMALE; HEART LEFT VENTRICLE; HEART RATE; HEMODYNAMICS; HUMAN; HYPEREMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR BLOCKING; VASCULAR RESISTANCE;

ADRENERGIC ALPHA-ANTAGONISTS; BLOOD PRESSURE; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; CORONARY STENOSIS; FEMALE; HUMANS; HYPEREMIA; MALE; MIDDLE AGED; PHENTOLAMINE; PIPERAZINES;

EID: 8444233526     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.09.003     Document Type: Article

References (26)

1. K.L. Gould, K. Lipscomb, and G.W. Hamilton Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve Am J Cardiol 33 1974 87 94
2. N.H.J. Pijls, and B. De Bruyne Coronary pressure 2nd ed 2000 Kluwer Academic Publishers Dordrecht, The Netherlands
3. Kern MJ, Horowitz JD, Ganz P, et al. Attenuation of coronary vascular resistance by selective alpha 1-adrenergic blockade in patients with coronary artery disease. J Am Coll Cardiol April 1985;5(4):840-6
4. B.K. Julius, G. Vassalli, and L. Mandinov Alpha-adrenoceptor blockade prevents exercise-induced vasoconstriction of stenotic coronary arteries J Am Coll Cardiol 33 1999 1499 1505
5. M.D. Winniford, K.R. Wheelan, and M.S. Kremers Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: evidence for adrenergically mediated alterations in coronary artery tone Circulation 73 1986 662 667
6. D. Baumgart, M. Haude, and G. Gorge Augmented α-adrenergic constriction of atherosclerotic human coronary arteries Circulation 99 1999 2090 2097
7. L. Gregorini, J. Fajadet, and G. Robert Coronary vasoconstriction after percutaneous transluminal coronary angioplasty is attenuated by antiadrenergic agents Circulation 90 1994 895 907
8. L. Gregorini, J. Marco, and M. Bernies The alpha-1 adrenergic blocking agent urapidil counteracts postrotational atherectomy "elastic recoil" where nitrates have failed Am J Cardiol 79 1997 1100 1103
9. L. Gregorini, J. Marco, and C. Palombo Postischemic left ventricular dysfunction is abolished by alpha-adrenergic blocking agents J Am Coll Cardiol 31 1998 992 1001
10. L. Gregorini, J. Marco, and M. Kozakova α-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction Circulation 99 1999 482 490
11. 2-adrenergic blockade on coronary flow reserve after coronary stenting Circulation 106 2002 2901 2907
12. E. Barbato, J. Bartunek, and E. Wyffels Effects of intravenous dobutamine on coronary vasomotions in humans J Am Coll Cardiol 42 2003 1596 1601
13. J.M.C.B. Hodgson, M.D. Cohen, and S. Szentpetery Effects of regional α- and β-blockade on resting and hyperemic coronary blood flow in conscious, unstressed humans Circulation 79 1989 797 809
14. J.H. Reiber, P.W. Serruys, and C.J. Kooijman Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms Circulation 71 1985 280 288
15. B. De Bruyne, N.H.J. Pijls, and E. Barbato Intracoronary and intravenous adenosine 5′-triphosphate, adenosine, papaverine and contrast medium to assess fractional flow reserve in humans Circulation 107 2003 1877 1883
16. 2-adrenergic constriction in the canine epicardial coronary microcirculation Circulation 87 1993 1264 1274
17. 2-adrenoceptor-mediated vasoconstriction of large and small canine coronary arteries in vivo J Cardiovasc Pharmacol 6 1984 961 968
18. 2-adrenoceptors Eur J Pharmacol 82 1982 199 202
19. A.E. Orlick, D.R. Ricci, and E.L. Alderman Effects of alpha adrenergic blockade upon coronary hemodynamics J Clin Invest 62 1978 459 467
20. R. Lorenzoni, S.D. Rosen, and P.G. Camici Effect of alpha1-adrenoceptor blockade on resting and hyperemic myocardial blood flow in normal humans Am J Physiol 271 1996 H1302 H1306
21. G.H. Mudge, W. Grossman, and R.M. Mills Reflex increase in coronary vascular resistance in patients with ischemic heart disease N Engl J Med 295 1976 1333 1337
22. 2- adrenoceptors in normal and atherosclerotic human coronary circulation Circulation 86 1992 1116 1124
23. M.A. Young, and S.F. Vatner Enhanced adrenergic constriction of iliac artery with removal of endothelium in conscious dogs Am J Physiol 250 1986 H892 H897
24. N.H. Pijls, B. De Bruyne, and K. Peels Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses N Engl J Med 334 1996 1703 1708
25. 2-adrenergic receptors in the regulation of myocardial performance during exercise in conscious dogs Circ Res 54 1984 683 693
26. D.G. Altman Practical statistics for medical research 1991 Chapman & Hall London, UK